Dermatologic agents during pregnancy and lactation: an update and clinical review

被引：39
作者：
Hale, EK [1 ]
Pomeranz, MK [1 ]
机构：
[1] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2002年 / 41卷 / 04期
关键词：
D O I：
10.1046/j.1365-4362.2002.01464.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：197 / 203
页数：7
相关论文
共 32 条
[1]  
*AM COLL OBST GYN, 1994, TECHN B AM COLL OBST, V193
[2]  
[Anonymous], 1999, MED LETT DRUGS THER, V41, P85
[3]  
Boothby LA, 2001, ANN PHARMACOTHER, V35, P1485
[4]  
BRANSKI D, 1986, J PEDIATR GASTR NUTR, V5, P316, DOI 10.1097/00005176-198605020-00028
[5]  
Briggs G., 1998, DRUGS PREGNANCY LACT, V5th
[6]  
Buck H W, 1998, Infect Dis Obstet Gynecol, V6, P49, DOI 10.1155/S106474499800012X
[7]   EPIDEMIOLOGY OF ISOTRETINOIN EXPOSURE DURING PREGNANCY [J].
DAI, WS ;
LABRAICO, JM ;
STERN, RS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (04) :599-606
[8]   Prospective controlled study of hydroxyzine and cetirizine in pregnancy [J].
Einarson, A ;
Bailey, B ;
Jung, G ;
Spizzirri, D ;
Baillie, M ;
Koren, G .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 78 (02) :183-186
[9]   COX-2-specific inhibitors -: the emergence of a new class of analgesic and anti-inflammatory drugs [J].
Everts, B ;
Währborg, P ;
Hedner, T .
CLINICAL RHEUMATOLOGY, 2000, 19 (05) :331-343
[10]  
HARAHAP M, 1996, SKIN CHANGES DIS PRE, P321
1234